迪哲医药18亿定增落地,多家机构抢筹入局

华尔街见闻
17 Apr

在创新药赛道激烈竞争的大背景下,头部企业的资本运作备受市场关注。 昨日,迪哲医药(688192.SH)公告宣布完成向特定对象发行A股股票,成功募集资金17.96亿元,成为“科八条”发布以来,再融资获得证监会注册的首家上交所未盈利企业。此次定增获得多家知名机构投资者支持, 定增细节:顶级机构竞相入场 市场数据显示,迪哲医药此次定增的发行价格为43.00元/股,共发行41,764,808股,较定价...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10